Valuation Finch Therapeutics Group, Inc.

Stocks

Market Closed - OTC Markets 15:12:40 2026-09-23 EDT			5-day change	1st Jan Change
10.35 ^USD	-1.43%		0.00%	-23.26%

09-03	Second Modified First Amended Combined Joint Liquidation Plan and Disclosure Stataement Approved for Finch Therapeutics Group, Inc.	CI
07-24	First Amended Disclosure Statement Conditionally Approved on an Interim Basis for Finch Therapeutics Group, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023
Market Cap ¹	473.4	22.99	5.797
Change	-	-95.14%	-74.79%
Enterprise Value (EV) ¹	345.9	4.311	10.8
Change	-	-98.75%	150.5%
P/E	-6.72x	-0.2x	-0.08x
PBR	2.34x	0.24x	0.25x
PEG	0.1x	-0x	0x
Capitalization / Revenue	25.5x	26.7x	54.2x
EV / Revenue	18.7x	5.01x	101x
EV / EBITDA	-6x	-0.05x	-0.33x
EV / EBIT	-5.77x	-0.05x	-0.32x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-44.51	-72.12	-46.59
Distribution rate	-	-	-
Net sales ¹	18.53	0.861	0.107
EBITDA ¹	-57.68	-89.61	-32.48
EBIT ¹	-59.98	-95.12	-34
Net income ¹	-58.16	-114.6	-74.75
Net Debt ¹	-127.4	-18.68	5.002
Reference price ²	299.10	14.40	3.61
Nbr of stocks (in thousands)	1,583	1,597	1,606
Announcement Date	3/31/22	3/23/23	3/25/24

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
FINCH THERAPEUTICS GROUP, INC.	-	-	-	-	16.62M
LONZA GROUP AG	33.26x	5.97x	17.88x	0.98%	47.97B
IQVIA HOLDINGS INC.	34.82x	3.35x	14.46x	-.--%	44.5B
REVOLUTION MEDICINES, INC.	-21.07x	227.64x	-22.77x	-.--%	43.93B
BEONE MEDICINES AG	47.27x	5.47x	29.96x	-.--%	41.03B
CELLTRION, INC.	26.85x	7.74x	19.93x	0.42%	29.85B
MEDPACE HOLDINGS, INC.	35.19x	5.78x	26.24x	-.--%	17.27B
EUROFINS SCIENTIFIC SE	25.79x	2.21x	9.6x	1.04%	15.3B
TEMPUS AI, INC.	-61.04x	9.99x	243.78x	-.--%	15.34B
Average	15.13x	33.52x	42.38x	0.3%	28.36B
Weighted average by Cap.	19.70x	43.80x	26.11x	0.3%